ACCESS Newswire
09 Aug 2019, 22:38 GMT+10
<_w3a_listitem> <_w3a_listitem> <_w3a_listitem> <_w3a_listitem> OTTAWA, ON / ACCESSWIRE / August 9, 2019 / Innovative Medicines Canada (IMC) warns that the amendments to the Patented Medicine Prices Review Board's (PMPRB) Regulations announced today will limit Canadian patients' access to new innovative medicines and discourage investment in Canada's life sciences sector for years to come.
"We have just received the amended Regulations and will require time to analyze them fully," stated Pamela Fralick, President of IMC. "However, given what we have heard to date, our fear is that patients will be worse off."
The PMPRB's own case studies indicate the amended Regulations will drop drug ceiling prices by up to 70 per cent, severely weakening the business case to launch new medicines in Canada. A recent EY study confirms that there is indeed a correlation between market conditions when it comes to global drug launch decisions, contrary to Health Canada' statements.
The amended Regulations will also have significant impacts on the future of Canada's life sciences sector, including a decline in investments and the loss of highly skilled jobs across the country. IMC notes that the outdated and narrow definition of research and development used by Health Canada does not reflect the current investments by this industry. According to a recent EY analysis, 10 per cent of industry revenues are invested into R&D.
"These regulatory changes have jeopardized our industry's incentive to invest in innovation in Canada," continued Ms. Fralick." The Regulations will also impact global decision making with respect to the launch of clinical trials in Canada, which are high-value health research activities that enable Canadian patients to benefit from early access to new and promising medicines free of charge."
The innovative pharmaceutical industry is currently the third largest R&D funder in Canada and contributes to a strong economy by supporting over 30,000 jobs and driving over $19-billion in annual economic activity.
IMC and its member companies, along with dozens of stakeholders - including some provincial governments, patient advocacy organizations, pharmacists, chambers of commerce, researchers and life sciences organizations - repeatedly urged the government to reconsider its approach. Recognizing the need for more affordable medicines, the industry offered to work collaboratively with government on an alternative solution that would balance the need for more affordable medicines with a competitive regulatory environment for health research. However, Health Canada did not meet with industry in a meaningful way on this issue, despite repeated requests.
"This is a disappointing day for those of us in the life sciences community, as well as for the many patients who will be worse off under these regulatory changes," stated Ms. Fralick. "As we evaluate the next steps for our industry, we remain committed to advocating for patient-centric solutions and a regulatory environment that fosters Canadian competitiveness."
About Innovative Medicines Canada
Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.
For further information:
CONTACT:
Sarah Dion-Marquis
Media Relations
Telephone: 613-769-6510
E-mail: [email protected]
SOURCE: Innovative Medicines Canada
Get a daily dose of BC Post news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to BC Post.
More InformationATLANTA, Georgia: The United States is facing its worst measles outbreak in more than three decades, with 1,288 confirmed cases so...
In the past month alone, 23 Israeli soldiers have been killed in Gaza—three more than the number of remaining living hostages held...
LONDON, U.K.: At least 13 people are believed to have taken their own lives as a result of the U.K.'s Post Office scandal, in which...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
SLUBICE, Poland: Poland reinstated border controls with Germany and Lithuania on July 7, following Germany's earlier reintroduction...
(Photo credit: Wendell Cruz-Imagn Images) Cody Bellinger hit three homers for the first time in his career and drove in six runs,...
(Photo credit: Neville E. Guard-Imagn Images) Willy Adames drove in three runs with a triple and a home run, Dominic Smith added...
(Photo credit: Ed Szczepanski-Imagn Images) Alejandro Kirk and Nathan Lukes each drove in two runs during a six-run fifth inning...
(Photo credit: Kirby Lee-Imagn Images) Pinch-hitter Travis d'Arnaud singled in Logan O'Hoppe from second with one out in the bottom...
Kingston [Jamaica], July 12 (ANI): Australia's Test captain Pat Cummins is set to sit out next month's white-ball series against South...
(Photo credit: Matt Marton-Imagn Images) Mike Tauchman delivered a game-ending infield single in the 11th inning and Lenyn Sosa homered...